The trademark IBULYSIN was filed by Vitabalans Oy, a corporation established under the laws of the Republic of Finland (the "Applicant"). The application was published for oppositions on August 12, 2024, and received one opposition filed on September 17, 2024 by Orifarm Generics Holding A/S on Likelihood of confusion. the opponent was represented by Bugge Valentin Advokatpartnerselskab and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 17, 2024
The application was filed in Finnish, and Finnish was also language of all opposition proceedings (English was selected as the second language).